Item 5. Market for Registrant’s Common Equity
ITEM 5. MARKET FOR REGISTRANT’S COMMON
EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Market Information . As of August
3, 2021, our common stock, par value $.001 per share (the “Common Stock”), is currently quoted on the Nasdaq Capital Markets
under the symbol “ABVC”.
Holders . As of March 31, 2023, we had approximately 666 shareholders
of record of our common stock.
Dividends . Holders of our common
stock are entitled to receive such dividends as may be declared by our board of directors. No dividends on our common stock have ever
been paid, and we do not anticipate that dividends will be paid on our common stock in the foreseeable future.
Recent Sales of Unregistered Securities .
During the period covered by this report, the
Company has not issued unregistered securities to any person, except as described below. None of these transactions involved any underwriters,
underwriting discounts or commissions, except as specified below, or any public offering, and, unless otherwise indicated below, the
Registrant believes that each transaction was exempt from the registration requirements of the Securities Act by virtue of
Section 4(a)(2) thereof and/or Rule 506 of Regulation D promulgated thereunder, and/or Regulation S promulgated
thereunder regarding offshore offers and sales. All recipients had adequate access, though their relationships with the Registrant, to
information about the Registrant.
During the year ended December 31, 2019, the Company
entered into service agreements with Euro-Asia Investment & Finance Corp Ltd. (a related party), Ever Adventure inv. (Formosa) Consultant
Co., Ltd., New Eastern Asia (a related party), and Kimho Consultants Co., Ltd. (a related party) for the maintenance of the listing in
the U.S. stock exchange market, investor relations, and business development. Pursuant to the agreements, the Company issued 644,972 shares
of the Company’s common stock for the consulting service from July 2019 to July 2024 for the service fee of $4,514,800 in aggregate,
and recorded as stock subscription receivable. As of December 31, 2022 and 2021, stock subscription receivable was $1,354,440 and $2,257,400,
respectively.
On January 21, 2020, the Company entered into
three note agreements with existing note investors who executed the agreements in 2018. These three investors are Guoliang Yu and Yingfei
Wei Family Trust, Keypoint Technology Ltd., and Yoshinobu Odaira. The new agreements bear the same term as other notes investors who
executed the contract in 2019. On April 5, 2020, the Company entered into exchange agreements with such note holders. Pursuant to the
exchange agreements, the Holders agreed to deliver the Notes to the Company for cancellation, of which the aggregate principal amount
plus accrued interest expenses are $931,584, and the Company issued to the Holders an aggregate of 506,297 shares of the Company’s
common stock, and warrants to purchase 506,297 shares of the Company’s common stock.
On April 5, 2020 and April 20, 2020, the Company
entered into certain exchange agreements separately with certain U.S. and non-U.S. holders who are holders of certain convertible promissory
notes issued by the Company in the aggregate amount of $1,446,780. Pursuant to the exchange agreements, the Company agreed to issue to
the Holders an aggregate of 795,735 shares of the Company’s common stock, and warrants to purchase 795,735 shares of common stock.
Each warrant is exercisable upon issuance and expires three years from the date of issuance. The initial exercise price of the warrant
is $5.00, subject to stock, splits, stock dividend and other similar events. In addition, when the closing price of the common stock
equals or exceeds $9.00 per share for twenty Trading Days (as defined in the exchange agreements) during any thirty-day period, the Company
shall have the right to require the holders to exercise all or any portion of the note holders’ warrants for a cash exercise. On
September 30, 2020, the Company has issued such note holders’ shares warrants to the holders and closed the transactions contemplated
by the Exchange Agreements.
In May 2020, the Company received capital contributions
of approximately $1,602,040 in cash from 40 investors through private placements of the sale of certain number of Common Stocks for the
purchase price of $2.25 per share of Common Stock and a free warrant attaches with each Common stock that was purchased. The exercise
price of the warrant is at $6.00 per common stock with a mandatory redemption at $9.00 per common stock pursuant to the terms and conditions
of the warrants.
On July 8, 2020, the Company entered an agreement
with View Trade Securities Inc. (“ ViewTrade ”) to engage ViewTrade as the placement agent and the Company’s advisor
with respect to its ongoing capital events. Pursuant to the agreement, the Company agreed to pay View Trade (“ ViewTrade Securities ”)
60,000 restricted common shares of the Company and 60,000 warrants to purchase common shares of the Company at an exercise price of $6
per share for a period of 5 years with cashless exercise provision. As of December 31, 2021, the Company has issued 60,000 shares of
common stock to ViewTrade for the advisory services with an estimated value of $135,000. The warrants were never issued and the parties
mutually agreed to terminate the agreement on November 19, 2020. As a termination fee, the Company agreed to issue ViewTrade 50,000 restricted
common shares of the Company.
Also on November 19, 2020, the Company and ViewTrade
agreed to a new Advisory agreement under which ViewTrade was engaged to provide advisory services only. In addition to a retainer fee,
the Company agreed to issue 200,000 warrants, with an exercise price of $2.25, an industry standard cashless exercise provision, and
a term of 5 years from November 19, 2020.
On September 30, 2020, the Company also issued
to Ever Adventure inv. (Formosa) Consultant Co., Ltd. (or its designee), Jinwei International Co., Ltd. (or its designee), and Thalia
Media Ltd. (or its designee) (the “ Consultants ”) 120,000 shares, 180,000 shares and 120,000 shares of common stock
(collectively, “ Consultants’ Shares ”), respectively, as their compensation as the Company’s investor relations
and business development advisors. Each Consultant has entered into certain consulting agreement with the Company.
37
On
September 30, 2020, the Company issued an aggregate of 795,735 shares of Common Stock to five previous note holders, who had converted
their outstanding principals and accrued and unpaid interests during 2020. For
the year ended December 31, 2022, no conversion was made to the note holders.
On November 8, 2020, the Company entered into
an exchange agreement with a holder of convertible promissory notes issued by the Company in the aggregate amount of $270,272. Pursuant
to the exchange agreements, the Company agreed to issue to the Holder an aggregate of 120,121 shares of the Company’s common stock,
and warrants to purchase 120,121 shares of common stock. On December 31, 2021, the Company issued an aggregated of 120,121 shares of
Common Stock to the note holder.
On November 11, 2020, the Company conducted a
closing with regard to certain securities purchase agreements (the “ SPAs ”) dated October 23, 2020, separately with
two non-U.S. investors (the “ Investors ”). Each of the Investors agreed to purchase and the Company agreed to sell
to each of the Investors 1,111,112 shares of the Company’s common stock, and warrants to purchase 1,111,112 shares of common stock,
for a purchase price of $2,500,000. The warrants are exercisable upon issuance and expires three years from the date of issuance. The
initial exercise price of the warrants is $6.00, subject to stock, splits, stock dividend and other similar events. In addition, when
the closing price of the common stock equals or exceeds $9.00 per share for twenty Trading Days (as defined in the exchange agreements)
during any thirty-day period, the Company shall have the right to require the investors to exercise all or any portion of the warrants
for a cash exercise. The aggregate net proceeds of the Offering were $5,000,000. The Company and the investors further agreed to amend
the terms of the SPA to permit the closing of the offering to occur on a rolling basis. In July 2021, 1,111,112 shares of the
Company’s common stock and warrants were issued pursuant to the conversion of a $2,500,000 convertible promissory note.
During the year ended December 31, 2020,
the Company entered into a consulting agreement with a service provider for consulting and advisory services, pursuant to which the Company
agreed to pay the service fee by issuing 50,000 shares of unrestricted common shares, valued at the closing price of $2.9 per
share on the grant date. These shares were issued in 2020.
During the year ended December 31, 2020, the
Company received aggregated capital contributions of $7,615,331 in cash from 45 investors through private placements of
the sale of the Company’s common stock for the purchase price of $2.25 per share and a free warrant attached with each
common stock purchased. In December 2020, 3,384,615 shares of the Company’s common stock have been issued.
During the year ended December 31, 2021, the
Company entered into consulting agreements with four service providers for consulting and advisory services, pursuant to which the Company
agreed to pay the aggregate service fee by issuing a total of 521,887 shares of unrestricted common shares, valued at the closing price
from $2 to $3.68 per share on the grant date. As of December 31, 2021, these shares have been issued.
During the year ended December 31, 2020, the
Company issued an aggregate of 915,856 shares of common stock to six previous note holders, who had converted their outstanding principals
and accrued and unpaid interests.
On August 5, 2021, the Company closed its
public offering (the “Public Offering”) of 1,100,000 units (the “Units”), with each Unit consisting of one share
of the Company’s common stock, one Series A warrant (the “Series A Warrants”) to purchase one share of common stock
at an exercise price equal to $6.30 per share, exercisable until the fifth anniversary of the issuance date, and one Series B warrant
(the “Series B Warrants,” and together with the Series A Warrants, the “Public Warrants”) to purchase one share
of common stock at an exercise price equal to $10.00 per share, exercisable until the fifth anniversary of the issuance date; the exercise
price of the Public Warrants are subject to certain adjustment and cashless exercise provisions as described therein. The Company completed
the Public Offering pursuant to its registration statement on Form S-1 (File No. 333-255112), originally filed with the Securities and
Exchange Commission (the “SEC”) on April 8, 2021 (as amended, the “Original Registration Statement”), that the
SEC declared effective on August 2, 2021 and the registration statement on Form S-1 (File No. 333-258404) that was filed and automatically
effective on August 4, 2021 (the “S-1MEF,” together with the Original Registration Statement, the “Registration Statement”).
The Units were priced at $6.25 per Unit, before underwriting discounts and offering expenses, resulting in gross proceeds of $6,875,000. The
Public Offering was conducted on a firm commitment basis. In August 2021, 2,354,145 shares of the Company’s common stock
were issued for gross proceeds of $6,875,000, before placement agent fees and legal fees of $850,429.
38
The Company paid the following fees to a FINRA
member firm in connection with the private financing transaction that closed on November 11, 2020: (i) a cash success fee of $175,000
and (ii) warrants to purchase a number of shares of Common Stock equal to 7% of the number of shares of Common Stock sold in this offering,
at an exercise price per share equal to $6.00 subject to adjustment (the “ Comp Warrants ”). The Comp Warrants are exercisable
on a cashless basis, at the holder’s discretion.
On June 29, 2021, we issued 6,000 shares of Common
Stock to WallachBeth as compensation for consulting services.
In November 2021, the Company issued an aggregate
of 316,934 shares of Common Stock to Consultants.
The Company also issued an aggregate of 1,306,007
shares of Common Stock to Consultants, who provided consulting services in January 2022; it issued an additional 75,000 shares to another
consultant in March 2022, based on the 6-month consulting and advisory services agreement, with a monthly payment of USD $15,000.
In November 2021, the Company issued 55,000 underwriter
warrants to WallachBeth, pursuant to the Company’s engagement of WallachBeth as the Company’s exclusive placement agent and
advisor in connection with the offering for the listing on The Nasdaq Capital Market.
In November 2021, the Company received $4,244,452 in
gross proceeds from the exercise of warrants issued in the Company’s August 3, 2021 public offering of securities. Investors exercised
a total of 673,405 Series A warrants at a price of $6.30 per share and 200 Series B warrants at a price of $10 per
share. Pursuant to these exercises, the Company issued an aggregate of 673,605 shares of Common Stock.
In January 2022, the Company agreed to pay the
deferred service fees related to the Offering amounting to $4,296,763 by issuing 1,306,007 shares of unrestricted common shares, valued
at $3.29 per share on the grant date.
In March 2022, the Company issued 75,000 shares
to BarLew Holdings, LLC, a consultant (“Barlew”). On January 1, 2022, the Company engaged Barlew for consulting and advisory
services for six months, with a monthly payment of USD15,000, as well as additional compensation of 75,000 shares of restricted common
stock.
In March 2022, the Company issued 242,247 warrants
to a FINRA member firm.
On May 11, 2022, the
Company and certain investors entered into certain securities purchase agreement relating to the offer and sale of 2,000,000 shares
of common stock, par value $0.001 per share in a registered direct offering.
On July 10, 2022, the
Board approved the issuance of 75,000 shares of common stock to Barlew Holdings, LLC pursuant to the consulting agreement by and between
Barlew Holdings, LLC and the Company dated July 1, 2022, and 250,000 shares of common stock to Inverlew Advisors, LLC, in accordance with
the consulting agreement by and between Inverlew Advisors, LLC and the Company dated July 1, 2022.
On December 1, 2022, the Company issued 125,000
and 100,000 common shares to Euro-Asia Investment & Finance Corp Ltd. and Thalia Media Ltd. for consulting and advisory services.
On January 3, 2023, the Company issued 223,411
common shares to a consultant for providing consulting services on listing to NASDAQ in 2021.
On February 23, 2023, the Company entered into a securities purchase
agreement with Lind Global Fund II, LP (“Lind”), pursuant to which the Company issued Lind a secured, convertible note in
the principal amount of $3,704,167, for a purchase price of $3,175,000, that is convertible into shares of the Company’s common
stock at an initial conversion price of $1.05 per share, subject to adjustment. The Company also issued Lind a common stock purchase warrant
to purchase up to 5,291,667 shares of the Company’s common stock at an initial exercise price of $1.05 per share, subject to adjustment.
39
ITEM 6. [Reserved]